Stent-based delivery of decoy oligodeoxynucleotides against activator protein-1 binding site decreased restenosis in rabbits

Author： Lin Kaimin Zhao Ziwen Chen Lianglong

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.8, 2013-08, pp. : 661-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Stent-based drug-delivery systems: current challenges and future trends

By Mani Gopinath

Therapeutic Delivery, Vol. 4, Iss. 9, 2013-09 ,pp. : 1079-1082

Future Science

Access to resources Recommend Favorite

Application of Decoy Oligodeoxynucleotides-Based Approach to Renal Diseases

Current Drug Targets, Vol. 5, Iss. 8, 2004-11 ,pp. : 717-733

Bentham Science Publishers

Access to resources Recommend Favorite

Paclitaxel-eluting stent safe, effective against restenosis

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

The drug-based pipeline against restenosis

By Keller Pierre-Frédéric Ibrahim Reda Tardif Jean-Claude

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 67-86

Informa Healthcare

Access to resources Recommend Favorite

Chronic ethanol enhances muscarinic receptor-mediated activator protein-1 (AP-1) DNA binding in cerebellar granule cells

By Cebers G. Hou Y.-N. Cebere A. Terenius L. Liljequist S.

European Journal of Pharmacology, Vol. 383, Iss. 2, 1999-10 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite